Testing effectiveness (Phase 2)Active Not RecruitingNCT03459846
What this trial is testing
Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)
Who this might be right for
Urinary Bladder Neoplasms
AstraZeneca 154